59 days ago
I have been a long term critic of both Hemogenyx (HEMO) and of its directors, the pompous arse Vlad Sandler and 214 year old Peter Redmond. The shares were pumped to highs of 1153p earlier thus year allowing a funding at 800p. But I’ve been doing the Winni-maths and Vlad and Pete (should that be Pete & Dud*?) should SMTM, or rather lack of it and ‘fess up to when the next placing is needed.
86 days ago
Hemogenyx (HEMO) has today served up more ramptastic news from the Baltic states and updated us on the pedestrian pace of its phase 1 drug trials. There is a killer phrase buried at the bottom of the release. First do the maths.
337 days ago
With just three patients in phase 1 trials Hemogenyx (HEMO) is at an incredibly early stage of drug development. But at least it is doing something, until recently it has just been a lifestyle business for its cock of a CEO Vlad Sandler. Today a prospectus is out, allowing yet more confetti to start trading. Turn to page 7
393 days ago
With a hap tip to readers T and K the details of the US phase 1 trial of Hemogenyx’s (HEMO) AML drug can now be revealed and it is not good news for deluded fools like Christopher Kilner who own the shares. Oh no…
399 days ago
I was promised an imminent update of the health status of patients 1 and 2 by an advisor to overpromoted box of snakes shitco Hemogenyx (HEMO) two days ago. I have heard nothing which makes me fear for their health. They will be in my prayers tonight since had they been running half marathons I would have had a speedy response saying just that. And this silence, as I explained HERE, should make shareholders run for the hills.
401 days ago
Forgive my reminiscing back to, I think, 1995 or maybe 1996 but this is pertinent as I consider the valuaton of Hemogenyx (HEMO) and what Vlad Sandler is NOT telling us about his phase 1 trials.
422 days ago
Shares in the worthless lifestyle company Hemogenyx (HEMO) have raced ahead by 68% today to 316p after a placing raising gross proceeds of £570,000 at 180p was announced yesterday. Lets call it £520,000 net and that tells you that ghastly boss Vald Sandler will be passing the hat around yet again before Christmas.
530 days ago
It was running on vapours so it’s no shock that Hemogenyx (HEMO), the pointless main market listed lifestyle company run by pompous prick Vlad Sandler has placed yet again, raising £451,000 gross at 180.5p. That will keep the wolf from the door for a couple of months by when Vlad will have to do another funding. But this one stinks, the RNS looks like its a lie.
567 days ago
585 days ago
591 days ago
604 days ago